IL64501A - 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use - Google Patents

9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use

Info

Publication number
IL64501A
IL64501A IL64501A IL6450181A IL64501A IL 64501 A IL64501 A IL 64501A IL 64501 A IL64501 A IL 64501A IL 6450181 A IL6450181 A IL 6450181A IL 64501 A IL64501 A IL 64501A
Authority
IL
Israel
Prior art keywords
preparation
hydroxybutyl
substituted
guanine derivatives
antiviral use
Prior art date
Application number
IL64501A
Other languages
English (en)
Other versions
IL64501A0 (en
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of IL64501A0 publication Critical patent/IL64501A0/xx
Publication of IL64501A publication Critical patent/IL64501A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
IL64501A 1980-12-22 1981-12-10 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use IL64501A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8009040 1980-12-22

Publications (2)

Publication Number Publication Date
IL64501A0 IL64501A0 (en) 1982-03-31
IL64501A true IL64501A (en) 1985-07-31

Family

ID=20342543

Family Applications (1)

Application Number Title Priority Date Filing Date
IL64501A IL64501A (en) 1980-12-22 1981-12-10 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use

Country Status (17)

Country Link
US (1) US4495190A (da)
EP (1) EP0055239B1 (da)
JP (1) JPS57501963A (da)
AT (1) ATE20748T1 (da)
AU (1) AU542373B2 (da)
CA (1) CA1172633A (da)
DE (1) DE3174948D1 (da)
DK (1) DK148279C (da)
FI (1) FI68054C (da)
GR (1) GR76971B (da)
IL (1) IL64501A (da)
NO (1) NO822712L (da)
NZ (1) NZ199334A (da)
RO (1) RO85288B (da)
SU (2) SU1272991A3 (da)
WO (1) WO1982002202A1 (da)
ZA (1) ZA818781B (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8203855D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine i
SE8203856D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine ii
HUT36464A (en) * 1983-05-24 1985-09-30 Newport Pharmaceuticals Process for producing erythro-4-amino-3-/2-hydroxy-3-alkyl/-imidazol-5-carboxamide
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
GB8320308D0 (en) * 1983-07-28 1983-09-01 Wellcome Found Antiviral combinations
US5684153A (en) 1984-08-16 1997-11-04 Beecham Group Plc Process for the preparation of purine derivatives
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
US4801710A (en) * 1984-10-26 1989-01-31 Merck & Co., Inc. Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives
YU45690B (sh) * 1984-12-22 1992-07-20 Krka Tovarna Zdraviln.Sol.O. Postopek za pripravo 9-(2-hidroksietoksimetil)-gvanina
EP0193454A1 (en) * 1985-02-25 1986-09-03 Merck & Co. Inc. 8-Substituted-9-hydroxyalkyl and hydroxyalkoxymethyl-guanines and pharmaceutical compositions containing them
EP0219838A3 (en) * 1985-10-22 1988-04-06 Takeda Chemical Industries, Ltd. Carbocyclic purine nucleosides, their production and use
US5578468A (en) * 1987-08-10 1996-11-26 Duke University Site-specific RNA cleavage
US5443964A (en) * 1987-08-10 1995-08-22 Duke University Poxvirus insertion/expression vector
US4935427A (en) * 1987-12-31 1990-06-19 The United States Of America As Represented By The Department Of Health And Human Services Pyrimidine and purine 1,2-butadiene-4-ols as anti-retroviral agents
US4966895A (en) * 1989-02-02 1990-10-30 Merck & Co. Inc. Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents
US5352669A (en) * 1990-03-13 1994-10-04 The Of The United States Of America As Represented By The Department Of Health And Human Services O6 -benzylated guanine, guanosine and 2'-deoxyguanosine compounds possessing O6 -alkylguanine-DNA alkyltransferase depleting activity
US5091432A (en) * 1990-03-28 1992-02-25 Glasky Alvin J 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use
CZ285420B6 (cs) * 1990-04-24 1999-08-11 Ústav Organické Chemie A Biochemie Avčr N-(3-Fluor-2-fosfonylmethoxypropyl)deriváty purinových a pyrimidinových heterocyklických bazí, způsoby jejich přípravy a použití
US5368853A (en) * 1990-05-11 1994-11-29 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Leukoregulin anti-viral therapy
JP2939646B2 (ja) * 1990-07-17 1999-08-25 チッソ株式会社 ４―置換―２―ヒドロキシブタン酸エステルおよび製造法
US5874578A (en) * 1992-07-13 1999-02-23 Bristol-Myers Squibb Process for preparing guanine-containing antiviral agents and purinyl salts useful in such process
US5525606A (en) * 1994-08-01 1996-06-11 The United States Of America As Represented By The Department Of Health And Human Services Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines
US6359114B1 (en) 1995-06-07 2002-03-19 Aphton Corp. System for method for the modification and purification of proteins
US6060458A (en) * 1998-02-13 2000-05-09 The United States Of America As Represented By The Department Of Health And Human Services Oligodeoxyribonucleotides comprising O6 -benzylguanine and their use
US20070129334A1 (en) * 2001-10-30 2007-06-07 Conforma Therapeutics Corporation Orally Active Purine-Based Inhibitors of Heat Shock Protein 90
EP2336133A1 (en) * 2001-10-30 2011-06-22 Conforma Therapeutics Corporation Purine analogs having HSP90-inhibiting activity
US7138401B2 (en) 2003-09-18 2006-11-21 Conforma Therapeutics Corporation 2-aminopurine analogs having HSP90-inhibiting activity
NZ561939A (en) * 2005-03-30 2011-03-31 Conforma Therapeutics Corp Alkynyl pyrrolopyrimidines and related analogs as HSP90-inhibitors
CA2653247C (en) * 2005-06-14 2012-12-18 Brigham Young University Methods for selective n-9 glycosylation of purines
WO2007035963A2 (en) * 2005-09-23 2007-03-29 Conforma Therapeutics Corporation Anti-tumor methods using multi drug resistance independent synthetic hsp90 inhibitors
CN108912055B (zh) * 2018-08-20 2020-06-30 河南师范大学 一种合成抗病毒药物西多福韦中间体和布昔洛韦中间体的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL34188A (en) * 1969-04-09 1972-12-29 Seiyaku T Co 4-(9-adenyl)-2,3-dihydroxy butyric acid and the preparation thereof
US3836656A (en) * 1972-02-07 1974-09-17 Sandoz Ag Substituted purines as hypolipidemics
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
US4230708A (en) * 1977-10-20 1980-10-28 Stichting Rega V.Z.W. Therapeutic application of (S) -or (RS)-9-(2, 3-dihydroxypropyl) adenine for use as antiviral agents
CS199093B1 (en) * 1977-10-20 1980-07-31 Antonin Holy Antiviral agent
US4221910A (en) * 1978-09-15 1980-09-09 Newport Pharmaceuticals International, Inc. 9-(Hydroxy alkyl)purines
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds

Also Published As

Publication number Publication date
FI822891A0 (fi) 1982-08-19
ATE20748T1 (de) 1986-08-15
IL64501A0 (en) 1982-03-31
EP0055239B1 (en) 1986-07-16
US4495190A (en) 1985-01-22
FI68054C (fi) 1985-07-10
WO1982002202A1 (en) 1982-07-08
SU1272991A3 (ru) 1986-11-23
JPS57501963A (da) 1982-11-04
DK148279B (da) 1985-05-28
NZ199334A (en) 1985-09-13
AU7872181A (en) 1982-07-01
FI68054B (fi) 1985-03-29
DK369982A (da) 1982-08-18
DE3174948D1 (en) 1986-08-21
RO85288B (ro) 1984-11-30
AU542373B2 (en) 1985-02-21
DK148279C (da) 1986-02-17
SU1272992A3 (ru) 1986-11-23
NO822712L (no) 1982-08-09
EP0055239A1 (en) 1982-06-30
FI822891L (fi) 1982-08-19
CA1172633A (en) 1984-08-14
RO85288A (ro) 1984-11-25
ZA818781B (en) 1982-11-24
GR76971B (da) 1984-09-04

Similar Documents

Publication Publication Date Title
IL64501A (en) 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use
ES8800946A1 (es) Un procedimiento para preparar derivados de guanina
ES2001094A6 (es) Un procedimiento para la preparacion de un derivado de guanina
GB2122198B (en) Antiviral guanine derivatives
AU584235B2 (en) New tricyclic compounds, processes for the preparation thereof and pharmaceutical compositions containing them
DE3363376D1 (en) Novel derivatives of guanine
ES516158A0 (es) Procedimiento de preparacion de nuevos derivados del adamantano.
SE8202433L (sv) Linkomycin-3-(5'-ribonukleotider)lempade for behandling av protosoriska sjukdomar